Contributing to Queensland’s Biotech Ecosystem at Nucleate Australia Panel

Written By Ketim Technologies

Brisbane, Australia – March 3, 2026 – Dr. Clarissa Yates, Founder and CEO of Ketim Technologies, was invited to join a panel discussion hosted by Nucleate Australia in partnership with UniSC Innovation Centre.

The event focused on Queensland’s growing life sciences ecosystem, bringing together industry leaders to discuss commercialisation pathways, diagnostic innovation, and the transition from research to industry impact.

The discussion explored the translation of biomarker discovery into clinically deployable diagnostics, alongside regulatory, manufacturing, and investment considerations in emerging health technologies.

Participation reflects Ketim’s ongoing engagement within Queensland’s MedTech community as the company advances development of its predictive blood-based diagnostic for postpartum depression.

For media inquiries, please contact:
Dr. Clarissa Yates
CEO, Ketim Technologies
clarissa.yates@ketim.com.au

Ketim Technologies

https://www.ketim.com.au
Previous

Panel Participation at Women in Technology International Women’s Day 2026
Next

AIIA Feature Highlights iAwards Journey and National Recognition